Publication | Closed Access

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Cervical CancerMedicinePathologyPhase Ii StudyOral LapatinibHead And Neck CancerHead And Neck Squamous Cell CarcinomaCancer TreatmentNeck OncologyOncologyRadiation OncologyOral Cancer